K Sawada ¹, N Masaki, S Hayashi, M Zeniya, T Ishikawa, H Takahashi, K Ohnishi, K Fukunaga, N Hara, T Yamamoto, T Hada, G Toda, J Viral Hepat. 2005 May;12(3):274-82.

In conclusion, enhanced efficacy of IFN/RBV following GMA might be attributed to a more efficient immune function and a renewed IFN signaling towards HCV.

https://pubmed.ncbi.nlm.nih.gov/15850468/